Supreme Court ‘Chevron’ Ruling Increases Pressure on Congress to Act on 340B But Unlikely to Immediately Impact Program Oversight

Hospital groups are urging the Supreme Court to correct what they called HHS' misinterpretation of DSH percentage calculations.
A landmark Supreme Court decision to limit the broad regulatory authority of federal agencies will increase pressure for Congress to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Viatris Becomes 37th Manufacturer to Place Restrictions on 340B Contract Pharmacy Use; Policy Applies to Hospitals and Health Centers

Drug manufacturer Viatris has placed 340B contract pharmacy restrictions on hospitals and community health centers.
Canonsburg, Penn.-based Viatris yesterday became the 37th drugmaker to restrict the shipment of 340B-priced drugs in the contract pharmacy setting. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More Drugmakers Exempt States from Contract Pharmacy Restrictions as Four New State Laws Take Effect

Four major drug manufacturers announced they will fully or partially exempt covered entities in certain states from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Delaware Legislature Passes Anti-Discrimination Protections for 340B Providers from PBMs but Drug Manufacturer Restrictions Remain

Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday.
Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Urge Federal Court to Uphold Maryland’s 340B Contract Pharmacy Access Law

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals in Texas and Other States Sue HHS Over DSH Calculation Changes That Impact 340B Eligibility

Dozens of hospitals in Texas and other states have filed suit against HHS to block a rule that they say lowers their disproportionate share hospital adjustment percentage and could result in a loss of 340B discounts.
Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

How to Leverage AI for Enhanced 340B Program Management: Learn More on 9/25 at 1PM ET

SPONSORED CONTENT

Artificial Intelligence (AI) is making significant strides in healthcare, and its potential impact on the 340B Drug Pricing Program is becoming increasingly evident.

What can AI do for 340B?

AI offers

Read More »

New York Times Sues HRSA To Release 340B Data, Communications Between Office of Pharmacy Affairs and Apexus Leaders; Information Could Be Released Soon

A federal court sided with a group of Texas hospitals’ efforts to block an HHS rule.
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days Before New Laws Go Into Effect, GSK, Pfizer Exempt Additional States from Contract Pharmacy Restrictions

GlaxoSmithKline wordmark and GSK logo on a building
GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.
Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Navigating HRSA 340B Program Audits

SPONSORED CONTENT

In the complex landscape of healthcare, compliance with the Health Resources and Services Administration’s (HRSA) 340B program is paramount for covered entities. As organizations strive to optimize their participation in the program, one critical aspect is preparing for HRSA audits. To shed light on this crucial process, we

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live